Traylor Margie L. 4
4 · Augmedix, Inc. · Filed Jun 16, 2023
Insider Transaction Report
Form 4
Augmedix, Inc.AUGX
Traylor Margie L.
Director
Transactions
- Purchase
Common Stock
2023-06-14$4.51/sh+26,529.75$119,649→ 47,330.75 total - Exercise/Conversion
Common Stock
2023-06-16+52,632→ 99,962.75 total - Exercise/Conversion
Restricted Stock Units
2023-06-16+52,632→ 0 total→ Common Stock (52,632 underlying)
Footnotes (3)
- [F1]This transaction was executed in multiple trades ranging from $4.47 to $4.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's common stock.
- [F3]On June 16, 2022 (the "Grant Date"), the reporting person was granted 52,632 RSUs which vested in full on the one-year anniversary of the Grant Date.